PATENT CLAIM ANALYSIS

Application Number: 16086717
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["424", "489000"]

Abstract:
The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.

Claim (Index 4):
The lyophilized pharmaceutical composition of  claim 3 , wherein the reconstituted composition comprises about 10 to about 100 mg/mL; about 20 to about 80 mg/mL; about 30 to about 80 mg/mL; about 40 to about 80 mg/mL; about 40 to about 70 mg/mL; about 40 to about 60 mg/mL; or about 40 to about 50 mg/mL concentration of the polymeric nanoparticles.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.14286
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13664133', '15296350', '13916133', '13862090', '13909670']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8169585539732057
- 35 USC 102 Novelty (BERT): 0.5753105830133056
- Combined Prediction Score: 0.7927937568772156
- Mean Citation Score: 488.226772
- Max Citation Score: 495.44614
- Similarity Product: 397.3477974288333

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test